FemPulse wins FDA IDE to use overactive bladder vaginal ring in pivotal trial
FemPulse is set to enter the pivotal clinical trial phase with its neuromodulation system to treat overactive bladder after the US Food and Drug Administration (FDA) awarded the company an investigational device exemption (IDE). The prospective, …